Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Humana

UnitedHealth Group

A new service-fee transparency law should be an easy hurdle to jump for America's largest healthcare providers.

Here's Why UnitedHealth, Humana, and Cigna Soared in November

Cigna (NYSE: CI) is a health services company that offers Medicare and Medicaid products and health, life and accident insurance coverage to US citizens. The company has seen its stock price rise by more than 50% in last one month.

Why Has Cigna’s Stock Rocketed 50% In The Last 30 days?

Let's see if Cigna Corporation (CI) stock is a good choice for value-oriented investors right now from multiple angles.

Is Cigna Corporation (CI) a Solid Value Investor Pick Now?

Brookdale Senior Living

Encompass Health

Fresenius Medical Care

HCA Healthcare

Healthcare Services Group

MEDNAX

The doctor is ordering you to protect your portfolio by avoiding these seven healthcare stocks. There are better investments elsewhere.

7 Sickly Healthcare Stocks to Avoid

AbbVie

Agile Therapeutics

Cardinal Health

Immunomedics

Golden crosses and death crosses are common signals in technical analysis and refer to the relationship between short-term and long-term moving averages.

AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses

Anthem

Centene

CVS Health

Tenet Healthcare

Hospital and managed care stocks surged Friday as Wall Street saw President Trump's medical price transparency rules as reason to buy health care stocks.

UnitedHealth, HCA Break Out As Health Care Stocks Jump For Trump Medical Price Transparency

Community Health Systems

Health Care Select Sector SPDR Fund

Health-care stocks rose Friday after President Donald Trump discussed his administration’s new rule that will force hospitals to disclose the discounted prices they negotiate with insurers.

Health-care stocks rise as Trump talks new price disclosure rules for hospitals and insurers

Veeva Systems

You don't need to avoid healthcare stocks completely. Just be careful where you invest.

Healthcare Stocks: 1 Buy, 1 Sell, 1 Hold

BB&T

Diamondback Energy

With third-quarter earnings reporting winding down, and the fourth quarter of 2019 well underway, many of the top companies we follow on Wall Street are tweaking the lists of their high-conviction stock picks for clients.

3 Merrill Lynch US 1 Stocks That Could Rule for Investors in 2020

As open enrollment for health insurance is underway, it's a good time to take a closer look at how health insurers are doing.

It's Time For Open Enrollment! How Healthy Are Anthem and Cigna?

Strong earnings from the industry leader lifted all three insurers by 15% or more.

Here's Why Cigna, Humana, and UnitedHealth Group Soared in October

Cigna Corporation (CI) CEO David Cordani on Q3 2019 Results - Earnings Call Transcript

The health insurer posted solid growth in all of its businesses, but the key factor in the third quarter was its big buyout last year.

Cigna Tops Q3 Estimates With a Big Boost From Its Express Scripts Acquisition

Cigna (CI) Q3 results reflect higher revenues and membership from Express Scripts merger.

Cigna (CI) Q3 Earnings & Revenues Beat Estimates, View Up

Cigna’s total revenue eclipsed $38 billion in the quarter while net income jumped to $1.35 billion, or $3.57 per share as the company benefits from the addition of the PBM Express Scripts, which the health insurer acquired in December of last year.

Express Scripts Boosts Cigna As Insurer Pushes ‘Whole Person’ Benefits

Cigna Corp  raised its full-year earnings target on Thursday, after reporting a better-than-expected quarterly profit boosted by its acquisition of pharmacy benefits manager Express Scripts last year.

Cigna raises 2019 forecast as Express Scripts buyout powers profit beat

Cigna (CI) delivered earnings and revenue surprises of 3.89% and 5.08%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Cigna (CI) Beats Q3 Earnings and Revenue Estimates

Cigna Corp  reported a 75% rise in quarterly profit on Thursday, benefiting from its acquisition of Express Scripts pharmacy benefits business last year.

Health insurer Cigna quarterly profit soars 75%

Cigna (CI) Q3 earnings are likely to have benefited from higher contribution across all its segments and effect of share buyback.

Cigna (CI) to Report Q3 Earnings: What's in the Offing?

Aramark

Chipotle

Philip Morris

Spirit AeroSystems Hlds

AllianceBernstein has combined quantitative and fundamental methods in a portfolio that has beaten the market handily for 15 years.

6 Leading Stocks From Bernstein's 'Quant + Fundamental' Portfolio

Mizuho recommended buying three health insurer stocks as it initiated coverage of the sector Thursday.

Mizuho Starts Bullish Coverage On Health Insurance Stocks

Cigna-owned Express Scripts buys Seattle-area health tech startup Verity Solutions

Fundamentals at Cigna are as strong as ever, with the company expected to grow EPS by 18% this year and about 10% next year.

Behind The Idea: Cigna - This Compounder Easily Has 50% Upside, Huge Insider Buying

Cigna (CI) closed the most recent trading day at $152.40, moving +1.04% from the previous trading session.

Cigna (CI) Gains But Lags Market: What You Should Know

Investors need to pay close attention to Cigna (CI) stock based on the movements in the options market lately.

News for Cigna Stock (CI)